Hypovitaminosis D and nocturnal hypertension in obese children: an interesting link

C Banzato1, C Maffeis1, E Maines1

  • 1Department of Life and Reproduction Sciences, Section of Pediatrics, University of Verona, Verona, Italy.

Insights

Low vitamin D levels in obese children are linked to increased blood pressure (BP) burden, particularly at night. This study highlights the importance of vitamin D for cardiovascular health in pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Nutritional Science

Background:

  • Low vitamin D levels are associated with hypertension in adults.
  • Obesity in children presents unique health challenges, including cardiovascular risks.

Purpose of the Study:

  • To investigate the association between 24-hour ambulatory blood pressure (BP) patterns and vitamin D levels in obese children.
  • To determine if vitamin D deficiency correlates with increased BP burden in this pediatric population.

Main Methods:

  • Recruited 32 obese children (ages 7-16).
  • Measured anthropometric parameters and serum 25-hydroxyvitamin D levels.
  • Monitored 24-hour ambulatory blood pressure (ABP), including BP load and BP index.

Main Results:

  • Children with lower vitamin D levels exhibited higher insulin resistance and increased nighttime systolic and diastolic BP, as well as higher BP load and index.
  • Vitamin D levels showed a negative correlation with 24-hour and nighttime systolic BP, systolic BP load, and nighttime systolic/diastolic BP index.
  • A higher prevalence of abnormal BP parameters was observed with increasing categories of vitamin D deficiency.

Conclusions:

  • Low vitamin D levels in obese children are associated with a significant increase in overall BP burden.
  • The findings suggest that maintaining adequate vitamin D levels may be crucial for managing blood pressure in obese children.
  • Further research is warranted to explore therapeutic interventions targeting vitamin D for cardiovascular risk reduction in pediatric obesity.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
498